Weighing particles at the attogram scale
New device from MIT can measure masses as small as one millionth of a trillionth of a gram, in solution.
Search Stories
Finding blood clots before they wreak havoc
Simple urine test developed by MIT engineers uses nanotechnology to detect dangerous blood clotting.
New way to target an old foe: malaria
Engineered liver tissue developed at MIT could help scientists test new drugs and vaccines.
3 Questions: Fiona Murray on female entrepreneurship
MIT professor discusses her research on the challenges facing women entrepreneurs, as well as possible solutions.
A step closer to artificial livers
Researchers identify compounds that help liver cells grow outside the body.
Grant to fund nanotech therapies for traumatic brain injuries
MIT’s Sangeeta Bhatia is part of the research team funded by the $6 million DARPA grant.
Abudayyeh named a Paul and Daisy Soros New American Fellow
2012 alumnus will use fellowship to support his studies in the Harvard/MIT MD-PhD Program.
Legatum Fellows bring innovation to emerging markets
Students see opportunities in the emerging economies of Asia, Africa and Latin America.
New technology may enable earlier cancer diagnosis
Nanoparticles amplify tumor signals, making them much easier to detect in the urine.
Tissue engineering: Growing new organs, and more
Research could lead to better ways to heal injuries and develop new drugs.
How cancer cells break free from tumors
New MIT study identifies adhesion molecules key to cancer’s spread through the body.
New nanoparticles shrink tumors in mice
Particles that shut off cancer genes could also allow researchers to screen potential drug targets more rapidly.
Measuring blood flow to monitor sickle cell disease
New technology may help doctors predict when patients are at risk for serious complications.
Stem cells could drive hepatitis research forward
By creating liver-like cells, scientists can study why people respond differently to the disease.
Recreating human livers, in mice
‘Humanized’ mice could help scientists study the side effects of new drugs before they reach clinical trials.